ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING MCGILL UNIVERSITY

Their core work

McGill University is a top-tier Canadian research university that serves as a transatlantic bridge for EU research collaborations, primarily hosting visiting researchers and contributing specialized expertise in genomics, health data science, and biomedical research. In H2020, McGill predominantly participates through Marie Skłodowska-Curie mobility actions, welcoming European fellows and contributing to researcher exchange networks. Their health research groups are deeply embedded in international cohort studies and federated data infrastructures connecting European, Canadian, and African biobanks. Beyond biomedicine, McGill contributes niche expertise across a remarkably wide range of fields — from climate economics and environmental science to digital humanities and musicology.

What they specialise in

How they've shifted over time

In the early period (2015-2018), McGill's H2020 involvement centered firmly on biomedical research — genomics, personalized medicine, cancer, chronic disease, and brain disorders — reflecting its traditional strength as a medical research powerhouse. From 2019 onward, the focus shifted markedly toward health data governance and infrastructure: data sharing ethics, cohort harmonization, metadata standards, and federated platforms became dominant themes. Simultaneously, a surprising expansion into arts and humanities appeared, with projects on sound studies, eighteenth-century sociability, and queer musicology gaining prominence in the later period.

McGill is moving from wet-lab biomedical research toward the data layer — expect future collaborations to center on federated health data, ethical governance of shared cohorts, and cross-continental research infrastructure.

How they like to work

McGill never coordinates H2020 projects — all 39 participations are as partner or third party (30 of 39 as third party, typically hosting MSCA fellows). This is characteristic of a non-EU institution that cannot lead Horizon projects but is highly sought after as a knowledge contributor. With 273 unique consortium partners across 45 countries, they are an exceptionally well-connected node, making them valuable for any consortium needing a strong North American research anchor.

McGill has collaborated with 273 unique partners across 45 countries, making it one of the most broadly networked non-EU participants in H2020. Their partnerships span all major EU research nations and extend into Africa (via CINECA), reflecting genuine global reach rather than a narrow bilateral corridor.

What sets them apart

As a leading Canadian university, McGill offers EU consortia something rare: a top-ranked North American research partner with deep integration into European research networks and proven experience navigating cross-continental data sharing frameworks (EU-Canada-Africa). Their dual strength in hard biomedical science and health data governance makes them especially valuable for projects that need both domain expertise and ethical/legal infrastructure for international data flows. For humanities consortia, McGill provides an unusual transatlantic perspective on European cultural and social history.

Highlights from their portfolio

• CINECA
  Ambitious tri-continental infrastructure linking European, Canadian, and African cohorts — positions McGill as a key node for global health data federation.
• euCanSHare
  Flagship EU-Canada joint cardiovascular data infrastructure built on FAIR principles, directly connecting McGill's health data expertise to European clinical research.
• EUCANCan
  Federated cancer genomics network standardizing data across institutions — McGill contributes genomics expertise and cross-border data harmonization experience.